Elevance Health (ELV) Interest Expenses (2009 - 2026)

Elevance Health (ELV) has 18 years of Interest Expenses data on file, last reported at $357.0 million in Q1 2026.

• Interest Expenses for Q1 2026 came in at $357.0 million, up 3.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 11.95% YoY), and the FY2025 annual result was $1.4 billion, up 18.31% from the prior year.
• Interest Expenses retreated to $357.0 million in Q1 2026 per ELV's latest filing, from $366.0 million in the prior quarter.
• Over five years, Interest Expenses peaked at $366.0 million in Q4 2025 and troughed at $201.0 million in Q1 2022.
• A 5-year average of $283.8 million and a median of $265.0 million in 2024 frame the typical range for Interest Expenses.
• The sharpest annual moves came in 2022 and 2024: Interest Expenses grew 1.46% in 2022, then surged 31.27% in 2024.
• A 5-year view of Interest Expenses shows it stood at $229.0 million in 2022, then grew by 13.1% to $259.0 million in 2023, then jumped by 31.27% to $340.0 million in 2024, then gained by 7.65% to $366.0 million in 2025, then slipped by 2.46% to $357.0 million in 2026.
• Business Quant data shows ELV's Interest Expenses at $357.0 million in Q1 2026, $366.0 million in Q4 2025, and $351.0 million in Q3 2025.